£890.00

The 2027-2032 World Outlook for At-Home Drug of Abuse Testing

Subjects

Price data last checked 100 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£890 today · cheaper than every other day in the last 4 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 25 days • 25 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 25 days • 1 price levels

Days at Price

Price Analysis

Most common price: £890 (25 days, 100.0%)

Price range: £890 - £890

Price levels: 1 different prices over 25 days

Description

This study covers the world outlook for at-home drug of abuse testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of at-home drug of abuse testing as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Assure Tech (Hangzhou) Company, Ltd., Confirm BioSciences, Express Diagnostics Int'l, Home Health (U.K.), Ltd., Orient New Life Medical Company, Ltd., Phamatech, Psychemedics, Quest Products, and UCP Biosciences, Inc.. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2026).

Product Specifications

Format: paperback
ASIN: B0GL265GKM
Category: Books > Subjects
Domain: Amazon UK
Release Date: 05 January 2026
Listed Since: 02 February 2026

The 2027-2032 World Outlook for At-Home Drug of Abuse Testing

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2025-2030 World Outlook for Point of Care Analyzers

The 2027-2032 World Outlook for Biotechnology Reagents

The 2026-2031 World Outlook for Lateral Flow Assay Meningitis Diagnostic Testing

The 2027-2032 World Outlook for Biotechnology Immunoassay Instrumentation Systems

The 2023 Report on DNA Testing: World Market Segmentation by City

The 2025-2030 World Outlook for DNA Testing

The 2025-2030 World Outlook for Point of Care Diagnostics

The 2027-2032 World Outlook for Biotechnology Molecular Diagnostics

The 2027-2032 World Outlook for Biotechnology Instrumentations

The 2023-2028 World Outlook for Electronic Trial Master File (eTMF) Systems

The 2023 Report on Point of Care Diagnostics: World Market Segmentation by City

The 2025-2030 World Outlook for Portable Medical Electronic Products

Wallach's Interpretation of Diagnostic Tests

Advances in Chromatographic Techniques for Therapeutic Drug Monitoring

Molecular Diagnostics: 133 (Advances in Biochemical Engineering/Biotechnology, 133)

The 2023 Report on Molecular Carrier Screening Tests: World Market Segmentation by City

The 2023-2028 World Outlook for In-Vivo Preclinical Imaging Modalities

The 2023-2028 World Outlook for In Vivo Toxicology Instruments

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan

Mosby's® Manual of Diagnostic and Laboratory Tests

Covid-19 Molecular Testing and Clinical Correlates, An Issue of the Clinics in Laboratory Medicine: Volume 42-2 (The Clinics: Internal Medicine, Volume 42-2)

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in India

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs for US Zip Codes